• Aller au contenu
• Aller à la navigation
• Aller à la recherche

Passer les liens principaux

• 
  • What's new?
  • About the EDQM & its Missions
  • History
  • Organigramme
  • Quality & Environmental Systems
  • The EDQM Library
  • Visit the EDQM
  • Contact us
• 
  • News and General Information
  • Blood Transfusion
    • Background & Missions
    • Organisation & Work Programme
    • Reports
    • Recommendations
  • Organ Transplantation
    • Background & Missions
    • Organisation & Work Programme
    • Reports
    • Recommendations
  • Pharmaceutical Care
    • Pharmaceuticals & Pharmaceutical care
    • Classification of medicines
    • Quality and safety pharmaceutical practices
    • Counterfeit medicines
• 
  • News and General Information
  • European Pharmacopoeia
    • Legal Status & Background
    • Mission & Structure
    • Members & Observership
    • How we work
    • How to participate in the PhEur work
    • Work Programme/Status
    • International Harmonisation
  • Reference Standards
    • Ph. Eur. Reference Standards
    • WHO ISA Standards
  • Biological Standardisation Programme
    • BSP Background & Missions
    • BSP Structure
    • BSP Methods of Work
    • BSP Work Programme/Achievements
• 
  • News and General Information
  • Why an OMCL Network?
  • Proficiency Testing Activities (PTS)
  • Quality Assurance Activities
  • Market Surveillance Study (MSS)
  • Human Biologicals (OCABR)
  • Veterinary Biologicals (OCABR/OBPR)
  • Centrally Authorised Products Testing (CAP)
  • MRP/DCP Post Marketing Surveillance Scheme
• 
  • News & General Information
  • Legal Status & Background
  • Missions & organisation
  • New Applications
  • Revisions & Renewals
  • Technical Advice/ One-to-One Meetings
  • Inspections
• 
  • Publications
    • The European Pharmacopoeia 6th Edition
    • Pharmeuropa, Pharmeuropa Bio & Scientific Notes
    • Standard Terms
    • Proceedings of International Conferences
    • Technical Guides
    • Batch Release Guidelines
    • Quality Assurance Activities Guidelines
    • Blood Transfusion & Organ Transplantation Guides
  • Reference Standards
    • EDQM Reference Standards
    • WHO International Standards for Antibiotics (ISA)
  • CombiStats
  • Proficiency Testing Studies (PTS)
  • Certificates of Suitability

Aller aux liens principaux

Homepage / The European Pharmacopoeia / European Pharmacopoeia / Work Programme/Status

Ph. Eur. Work Programme/Status

PhEur Work Programme

The European Pharmacopoeia Commission has set the goals of rapidly increasing the number of European monographs (more than 2000 available so far), reducing the time needed to elaborate them, and, if the need is expressed, elaborating monographs on recent substances still under patent protection.

Additions to the Ph Eur Work Programme (January 2009)

Modification Work Programme 062009
Modification of the Work Programme of the European Pharmacopoeia Commission (Decisions of the PhEur Commission, March 2009)

Hot Topics

Towards the 6th Edition (2007):
Special revision programme (impurities); Excipients: functionality-related properties;
Traditional herbal medicines (European, Chinese, Ayurvedic etc.);
Harmonisation with Japan and the USA (to continue);

For the 5th Edition (2004-2007):
Adapting to globalisation: impurities control for new sources;
New biological therapies (cell therapy, gene therapy products);
Modern methods in microbiology.

Knowledge Database

Status of the Ph. Eur. Work Programme

KNOWLEDGE will tell you if a specific substance or a method of analysis is part of the Pheur work programme, its state of work and additional useful information (chromatograms, trade names for chromatography colums). Access to KNOWLEDGE is also possible under DATABASES Menu (see left-hand side menu).